ResearcherYonsei UniversityActive in the last 2 years
Hei‐Cheul Jeung
Matched on ORCID iD 0000-0003-0952-3679; OpenAlex author ID A5041366420, A5159693914. Sources: OpenAlex.
Their work
- Papers
- 5 (first author 0, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 39
2016: 1 paper · 2017: 1 paper · 2018: none · 2019: 1 paper · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: 1 paper · 2026: 1 paper
Papers 5
- Efficacy of neoadjuvant FOLFIRINOX in resectable pancreatic cancer (NeoFOL-R): study protocol for an international, multicenter, prospective, randomized contro… Co-author DOI 10.1186/s12885-026-15639-6↗
- Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with pancreatic cancer. Co-author DOI 10.1016/j.esmoop.2025.105826↗
- Association between early nutritional risk and overall survival in patients with advanced pancreatic cancer: A single-center retrospective study. Co-author DOI 10.1016/j.clnesp.2019.01.012↗
- ANO9/TMEM16J promotes tumourigenesis via EGFR and is a novel therapeutic target for pancreatic cancer. Co-author DOI 10.1038/bjc.2017.355↗
- Prognostic Scoring Index for Patients with Metastatic Pancreatic Adenocarcinoma. Last author DOI 10.4143/crt.2015.400↗
Closest collaborators
The 25 strongest of 39 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Myung Ah Lee · 2 shared papers, 2025–2026 · strength 0.36
- Paper Efficacy of neoadjuvant FOLFIRINOX in resectable pancreatic cancer (NeoFOL-R): study protocol for an international, mul… DOI 10.1186/s12885-026-15639-6↗
- Paper Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with pancrea… DOI 10.1016/j.esmoop.2025.105826↗
- Julian Choi · 1 shared paper, 2026 · strength 0.19
- Jin-Young Jang · 1 shared paper, 2026 · strength 0.19
- Ju Won Kim · 1 shared paper, 2026 · strength 0.19
- Hye Jin Choi · 1 shared paper, 2026 · strength 0.19
- In Woong Han · 1 shared paper, 2026 · strength 0.19
- Yoo‐Seok Yoon · 1 shared paper, 2026 · strength 0.19
- Keun Soo Ahn · 1 shared paper, 2026 · strength 0.19
- Hye‐Sol Jung · 1 shared paper, 2026 · strength 0.19
- Chang-Sup Lim · 1 shared paper, 2026 · strength 0.19
- Hyung Il Seo · 1 shared paper, 2026 · strength 0.19
- Jung Yong Hong · 1 shared paper, 2026 · strength 0.19
- Do‐Youn Oh · 1 shared paper, 2026 · strength 0.19
- Jai Hoon Yoon · 1 shared paper, 2026 · strength 0.19
- Tae Ho Hong · 1 shared paper, 2026 · strength 0.19
- Wooil Kwon · 1 shared paper, 2026 · strength 0.19
- Krittiya Korphaisarn · 1 shared paper, 2025 · strength 0.17
- Thierry Conroy · 1 shared paper, 2025 · strength 0.17
- Cosmas Rinaldi Adithya Lesmana · 1 shared paper, 2025 · strength 0.17
- Wen‐Chi Chou · 1 shared paper, 2025 · strength 0.17
- Joycelyn Jie Xin Lee · 1 shared paper, 2025 · strength 0.17
- Chunyi Hao · 1 shared paper, 2025 · strength 0.17
- Glenn Kunnath Bonney · 1 shared paper, 2025 · strength 0.17
- Akihiro Ohba · 1 shared paper, 2025 · strength 0.17
- Li‐Tzong Chen · 1 shared paper, 2025 · strength 0.17
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.